[{"address1": "1111 Lincoln Road", "address2": "Suite 500", "city": "Miami Beach", "state": "FL", "zip": "33139", "country": "United States", "phone": "702 514 4174", "website": "https://www.pasithea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. Lawrence  Steinman BA, M.D., Ph.D.", "age": 76, "title": "Co-Founder, MD & Executive Chairman", "yearBorn": 1948, "fiscalYear": 2024, "totalPay": 250000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel H. Schneiderman", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 330000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.32, "open": 1.31, "dayLow": 1.25, "dayHigh": 1.39, "regularMarketPreviousClose": 1.32, "regularMarketOpen": 1.31, "regularMarketDayLow": 1.25, "regularMarketDayHigh": 1.39, "payoutRatio": 0.0, "beta": 0.749, "forwardPE": -1.8873241, "volume": 50339, "regularMarketVolume": 50339, "averageVolume": 1104198, "averageVolume10days": 96980, "averageDailyVolume10Day": 96980, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 1697016, "fiftyTwoWeekLow": 0.923, "fiftyTwoWeekHigh": 9.25, "fiftyDayAverage": 1.6021, "twoHundredDayAverage": 3.57566, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -3297676, "profitMargins": 0.0, "floatShares": 2594077, "sharesOutstanding": 1266430, "sharesShort": 7889, "sharesShortPriorMonth": 26658, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0062, "heldPercentInsiders": 0.089320004, "heldPercentInstitutions": 0.046469998, "shortRatio": 0.09, "shortPercentOfFloat": 0.0075, "impliedSharesOutstanding": 1266430, "bookValue": 10.603, "priceToBook": 0.12637934, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -13904584, "trailingEps": -12.69, "forwardEps": -0.71, "lastSplitFactor": "1:20", "lastSplitDate": 1704153600, "enterpriseToEbitda": 0.242, "52WeekChange": -0.81517243, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 1.34, "recommendationKey": "none", "totalCash": 6922729, "totalCashPerShare": 2.559, "ebitda": -13600933, "totalDebt": 0, "quickRatio": 6.182, "currentRatio": 6.58, "returnOnAssets": -0.42228, "returnOnEquity": -0.72835, "freeCashflow": -9000477, "operatingCashflow": -13923438, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "KTTA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Pasithea Therapeutics Corp.", "longName": "Pasithea Therapeutics Corp.", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1631712600000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.34, "postMarketChange": 0.0, "regularMarketChange": 0.01999998, "regularMarketDayRange": "1.25 - 1.39", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1104198, "fiftyTwoWeekLowChange": 0.41700006, "fiftyTwoWeekLowChangePercent": 0.4517877, "fiftyTwoWeekRange": "0.923 - 9.25", "fiftyTwoWeekHighChange": -7.91, "fiftyTwoWeekHighChangePercent": -0.85513514, "fiftyTwoWeekChangePercent": -81.51724, "exchange": "NCM", "messageBoardId": "finmb_702706441", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.51515, "regularMarketPrice": 1.34, "corporateActions": [], "postMarketTime": 1743199007, "regularMarketTime": 1743192000, "earningsTimestamp": 1742846400, "earningsTimestampStart": 1747080000, "earningsTimestampEnd": 1747425600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -12.69, "epsForward": -0.71, "fiftyDayAverageChange": -0.26209998, "fiftyDayAverageChangePercent": -0.16359776, "twoHundredDayAverageChange": -2.23566, "twoHundredDayAverageChangePercent": -0.625244, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-09-15", "cryptoTradeable": false, "displayName": "Pasithea Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]